<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>15(1)</volume><submitter>Tang Y</submitter><funding>The Singapore National Research Foundation</funding><pubmed_abstract>Photodynamic therapy (PDT) is a promising cancer treatment but has limitations due to its dependence on oxygen and high-power-density photoexcitation. Here, we report polymer-based organic photosensitizers (PSs) through rational PS skeleton design and precise side-chain engineering to generate •O&lt;sub>2&lt;/sub>&lt;sup>-&lt;/sup> and •OH under oxygen-free conditions using ultralow-power 808 nm photoexcitation for tumor-specific photodynamic ablation. The designed organic PS skeletons can generate electron-hole pairs to sensitize H&lt;sub>2&lt;/sub>O into •O&lt;sub>2&lt;/sub>&lt;sup>-&lt;/sup> and •OH under oxygen-free conditions with 808 nm photoexcitation, achieving NIR-photoexcited and oxygen-independent •O&lt;sub>2&lt;/sub>&lt;sup>-&lt;/sup> and •OH production. Further, compared with commonly used alkyl side chains, glycol oligomer as the PS side chain mitigates electron-hole recombination and offers more H&lt;sub>2&lt;/sub>O molecules around the electron-hole pairs generated from the hydrophobic PS skeletons, which can yield 4-fold stronger •O&lt;sub>2&lt;/sub>&lt;sup>-&lt;/sup> and •OH production, thus allowing an ultralow-power photoexcitation to yield high PDT effect. Finally, the feasibility of developing activatable PSs for tumor-specific photodynamic therapy in female mice is further demonstrated under 808 nm irradiation with an ultralow-power of 15 mW cm&lt;sup>-2&lt;/sup>. The study not only provides further insights into the PDT mechanism but also offers a general design guideline to develop an oxygen-independent organic PS using ultralow-power NIR photoexcitation for tumor-specific PDT.</pubmed_abstract><journal>Nature communications</journal><pagination>2530</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10957938</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Oxygen-independent organic photosensitizer with ultralow-power NIR photoexcitation for tumor-specific photodynamic therapy.</pubmed_title><pmcid>PMC10957938</pmcid><pubmed_authors>Tian J</pubmed_authors><pubmed_authors>Li Y</pubmed_authors><pubmed_authors>Huang W</pubmed_authors><pubmed_authors>Qi G</pubmed_authors><pubmed_authors>Liu B</pubmed_authors><pubmed_authors>Li B</pubmed_authors><pubmed_authors>Fan Q</pubmed_authors><pubmed_authors>Song W</pubmed_authors><pubmed_authors>Tang Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>Oxygen-independent organic photosensitizer with ultralow-power NIR photoexcitation for tumor-specific photodynamic therapy.</name><description>Photodynamic therapy (PDT) is a promising cancer treatment but has limitations due to its dependence on oxygen and high-power-density photoexcitation. Here, we report polymer-based organic photosensitizers (PSs) through rational PS skeleton design and precise side-chain engineering to generate •O&lt;sub>2&lt;/sub>&lt;sup>-&lt;/sup> and •OH under oxygen-free conditions using ultralow-power 808 nm photoexcitation for tumor-specific photodynamic ablation. The designed organic PS skeletons can generate electron-hole pairs to sensitize H&lt;sub>2&lt;/sub>O into •O&lt;sub>2&lt;/sub>&lt;sup>-&lt;/sup> and •OH under oxygen-free conditions with 808 nm photoexcitation, achieving NIR-photoexcited and oxygen-independent •O&lt;sub>2&lt;/sub>&lt;sup>-&lt;/sup> and •OH production. Further, compared with commonly used alkyl side chains, glycol oligomer as the PS side chain mitigates electron-hole recombination and offers more H&lt;sub>2&lt;/sub>O molecules around the electron-hole pairs generated from the hydrophobic PS skeletons, which can yield 4-fold stronger •O&lt;sub>2&lt;/sub>&lt;sup>-&lt;/sup> and •OH production, thus allowing an ultralow-power photoexcitation to yield high PDT effect. Finally, the feasibility of developing activatable PSs for tumor-specific photodynamic therapy in female mice is further demonstrated under 808 nm irradiation with an ultralow-power of 15 mW cm&lt;sup>-2&lt;/sup>. The study not only provides further insights into the PDT mechanism but also offers a general design guideline to develop an oxygen-independent organic PS using ultralow-power NIR photoexcitation for tumor-specific PDT.</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Mar</publication><modification>2025-04-22T12:56:59.033Z</modification><creation>2025-04-06T00:29:34.531Z</creation></dates><accession>S-EPMC10957938</accession><cross_references><pubmed>38514624</pubmed><doi>10.1038/s41467-024-46768-w</doi></cross_references></HashMap>